Exelixis (EXEL) Cash & Current Investments (2010 - 2026)

Exelixis (EXEL) recorded quarterly Cash & Current Investments of $777.2 million in Q2 2026, down 26.62% quarter-over-quarter from $1.1 billion in Q1 2026, and down 24.64% on a YoY basis from $1.0 billion in Q2 2025.

Exelixis (EXEL) Cash & Current Investments (2010 - 2026) Analysis & Trends

Exelixis' Cash & Current Investments history runs 17 years deep, the most recent figure standing at $777.2 million for Q2 2026.

  • In Q2 2026, Cash & Current Investments fell 24.64% year-over-year to $777.2 million; the TTM figure through Apr 2026 stood at $777.2 million (down 24.64% YoY), while the FY2026 annual figure was $1.1 billion, down 4.7% from the prior year.
  • Cash & Current Investments was $777.2 million for Q2 2026 at Exelixis, down from $1.1 billion in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $1.6 billion in Q2 2022 to a low of $777.2 million in Q2 2026.
  • Historically, Cash & Current Investments has averaged $1.2 billion across 5 years, with a median of $1.1 billion in 2023.
  • The sharpest annual moves came in 2022 and 2023: Cash & Current Investments jumped 32.46% in 2022, then retreated 28.68% in 2023.
  • A 5-year view of Cash & Current Investments shows it stood at $1.3 billion in 2022, then decreased by 23.93% to $995.3 million in 2023, then climbed by 19.48% to $1.2 billion in 2024, then slipped by 16.87% to $988.5 million in 2025, then dropped by 21.38% to $777.2 million in 2026.
  • The last three Cash & Current Investments figures came in at $777.2 million (Q2 2026), $1.1 billion (Q1 2026), and $988.5 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 32.30 Mn
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 2.13 Mn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 286.70 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 2.77 Mn
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - 18.44 Mn
7 Psyence Biomedical 227.32 Bn 227.31 Bn - 7.20 Mn
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 7.25 Bn
9 Abivax 91.71 Bn 91.71 Bn - -
10 Exelixis 13.61 Bn 12.83 Bn 590.86 Mn 777.21 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 777.21 Mn
Jan 2, 2026 1.06 Bn
Oct 3, 2025 988.54 Mn
Jul 4, 2025 791.10 Mn
Apr 4, 2025 1.03 Bn
Jan 3, 2025 1.11 Bn
Sep 27, 2024 1.19 Bn
Jun 28, 2024 1.00 Bn
Mar 29, 2024 963.26 Mn
Dec 29, 2023 995.30 Mn
Sep 29, 2023 1.10 Bn
Jun 30, 2023 1.27 Bn
Mar 31, 2023 1.31 Bn
Dec 30, 2022 1.31 Bn
Sep 30, 2022 1.55 Bn
Jul 1, 2022 1.53 Bn
Apr 1, 2022 1.57 Bn
Dec 31, 2021 1.47 Bn
Oct 1, 2021 1.40 Bn
Jul 2, 2021 1.35 Bn